As India grapples with a growing burden of diabetes and chronic wounds, a network of specialised wound-care Centres of Excellence is set to be rolled out across the country over the next two to three years, offering integrated diagnosis, treatment and long-term monitoring for patients with chronic and non-healing wounds.
The centres are being developed under the Wound Heal Plus initiative of IHLD MedTech, which has received an initial investment tranche of US$3 million from Singapore-listed UltraGreen.ai, with the potential for additional investments that could increase the total investment to up to US$12 million, subject to mutually agreed milestones and other agreed conditions. The funding will support the expansion of IHLD MedTech’s Wound Heal Plus and iLiveConnect platforms.
IHLD MedTech, an Indian medtech company building technology-led healthcare delivery platforms, said the centres would bring together wound screening, advanced imaging, treatment, rehabilitation and digital follow-up services under one roof, addressing what experts describe as a major but often neglected area of healthcare.
The investment will also support the expansion of iLiveConnect, a doctor-led, AI-enabled continuity-care platform designed to extend healthcare far beyond hospital walls.
Combining wearable biosensors, intelligent health patches, predictive analytics and an intelligent clinical supervision layer with real-time physician oversight, the platform is designed to identify early signs of medical deterioration, enable proactive intervention and support continuous patient engagement throughout the care journey.
From chronic disease management and preventive healthcare to elderly care and post-discharge monitoring, iLiveConnect seeks to bridge the gaps that often exist between hospital visits, creating a seamless continuum of care.
By combining artificial intelligence, predictive analytics and proactive clinical supervision, the platform aims to help transform healthcare from a largely reactive model into one that is predictive, preventive and continuously connected.
The company believes such continuity-care ecosystems have the potential to reshape healthcare delivery globally by helping clinicians anticipate risk, intervene earlier and improve patient outcomes.
“One of the biggest challenges in India, and indeed across the world, is that wound care remains a largely neglected area of healthcare,” Dr Rahul Chandola, cardiovascular surgeon and Founder and Managing Director of IHLD MedTech, said.
“There are very few comprehensive facilities that bring together all aspects of wound diagnosis, treatment and rehabilitation under one roof. Our centres aim to fill that gap while ensuring patients continue to receive expert care through digital monitoring and ongoing clinical support.
At the same time, we believe the future of healthcare lies beyond the hospital. Through iLiveConnect, our vision is to build a continuity-care ecosystem that combines artificial intelligence, predictive analytics and clinical expertise to keep patients connected to their healthcare teams throughout their journey. The long-term opportunity is to help shift healthcare globally from a reactive system focused on treating illness to a proactive and predictive model focused on preserving health, preventing complications and improving quality of life.”
“We believe the future of healthcare lies at the intersection of advanced technology, clinical intelligence and continuous patient engagement,” said Ravinder Sajwan, CEO of UltraGreen.ai.
“iLiveConnect and Wound Heal Plus represent innovative approaches to major global healthcare challenges. We are pleased to support IHLD MedTech’s next phase of growth and look forward to combining our capabilities to improve patient outcomes.”
India, often referred to as the diabetes capital of the world, has millions of people living with the disease, many of whom are at risk of developing diabetic foot ulcers because of complications such as neuropathy and poor blood circulation, Dr Chandola said.
“A significant number of diabetic patients develop complications such as neuropathy and vasculopathy, which increase their risk of developing diabetic foot ulcers. Millions of people suffer from such chronic wounds, which can severely affect their quality of life and, in many cases, lead to amputations if not treated properly,” he said.
The Wound Heal Plus centres will offer a multidisciplinary approach involving vascular surgeons, plastic surgeons, podiatrists, orthotists, nutritionists, physiotherapists and rehabilitation specialists.
A key feature of the programme is the use of advanced fluorescence imaging technology that allows clinicians to assess blood flow and tissue perfusion within wounds. The resulting images are analysed through WoundLinks, a software platform developed in collaboration with UltraGreen.ai, helping doctors identify poorly perfused tissue and make more precise treatment decisions, Dr Chandola said.
Beyond hospital-based treatment, patients will continue to receive care through iLiveConnect’s continuity-care platform and mobile wound-care clinics after discharge, enabling specialists to track healing, identify risks early and intervene when necessary.
“Our objective is to establish multiple Centres of Excellence across India over the next two to three years and subsequently replicate the model internationally,” Dr Chandola said.
“Alongside the expansion of Wound Heal Plus, we plan to scale iLiveConnect across India and pursue opportunities in the Middle East, Europe and North America through strategic partnerships and collaborations. Our vision is to build an integrated healthcare ecosystem that combines clinical excellence, advanced diagnostics, artificial intelligence and continuity of care to help make healthcare more predictive, proactive and accessible worldwide.”
